Behar-Cohen F - Search Results

1

Evaluating in vivo delivery of riboflavin with coulomb-controlled iontophoresis for corneal collagen cross-linking: a pilot study.

Arboleda A, Kowalczuk L, Savoldelli M, Klein C, Ladraa S, Naud MC, Aguilar MC, Parel JM, Behar-Cohen F. Arboleda A, et al. Invest Ophthalmol Vis Sci. 2014 Apr 28;55(4):2731-8. doi: 10.1167/iovs.14-13931. Invest Ophthalmol Vis Sci. 2014. PMID: 24667860

2

Lontophoresis for the treatment of paecilomyces keratitis.

Yoo SH, Dursun D, Dubovy S, Miller D, Alfonso E, Forster RK, Behar-Cohen F, Parel JM. Yoo SH, et al. Cornea. 2002 Jan;21(1):131-2. doi: 10.1097/00003226-200201000-00029. Cornea. 2002. PMID: 11805526 No abstract available.

3

Recurrence of keratoconus characteristics: a clinical and histologic follow-up analysis of donor grafts.

Bourges JL, Savoldelli M, Dighiero P, Assouline M, Pouliquen Y, BenEzra D, Renard G, Behar-Cohen F. Bourges JL, et al. Ophthalmology. 2003 Oct;110(10):1920-5. doi: 10.1016/S0161-6420(03)00617-1. Ophthalmology. 2003. PMID: 14522765

4

VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.

Normand N, Valamanesh F, Savoldelli M, Mascarelli F, BenEzra D, Courtois Y, Behar-Cohen F. Normand N, et al. Mol Vis. 2005 Mar 4;11:184-91. Mol Vis. 2005. PMID: 15761390 Free article.

5

Downregulation of endotoxin-induced uveitis by intravitreal injection of vasoactive intestinal Peptide encapsulated in liposomes.

Lajavardi L, Bochot A, Camelo S, Goldenberg B, Naud MC, Behar-Cohen F, Fattal E, de Kozak Y. Lajavardi L, et al. Invest Ophthalmol Vis Sci. 2007 Jul;48(7):3230-8. doi: 10.1167/iovs.06-1305. Invest Ophthalmol Vis Sci. 2007. PMID: 17591893

6

Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes.

Berdugo M, Bejjani RA, Valamanesh F, Savoldelli M, Jeanny JC, Blanc D, Ficheux H, Scherz A, Salomon Y, BenEzra D, Behar-Cohen F. Berdugo M, et al. Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1633-44. doi: 10.1167/iovs.07-0767. Invest Ophthalmol Vis Sci. 2008. PMID: 18385085

7

Poly-epsilon-caprolactone intravitreous devices: an in vivo study.

Silva-Cunha A, Fialho SL, Naud MC, Behar-Cohen F. Silva-Cunha A, et al. Invest Ophthalmol Vis Sci. 2009 May;50(5):2312-8. doi: 10.1167/iovs.08-2969. Epub 2008 Dec 30. Invest Ophthalmol Vis Sci. 2009. PMID: 19117927

8

Protective effect of intravitreal injection of vasoactive intestinal peptide-loaded liposomes on experimental autoimmune uveoretinitis.

Camelo S, Lajavardi L, Bochot A, Goldenberg B, Naud MC, Brunel N, Lescure B, Klein C, Fattal E, Behar-Cohen F, de Kozak Y. Camelo S, et al. J Ocul Pharmacol Ther. 2009 Feb;25(1):9-21. doi: 10.1089/jop.2008.0074. J Ocul Pharmacol Ther. 2009. PMID: 19232006

9

Subconjunctival injection of XG-102, a c-Jun N-terminal kinase inhibitor peptide, in the treatment of endotoxin-induced uveitis in rats.

El Zaoui I, Touchard E, Berdugo M, Abadie C, Kowalczuk L, Deloche C, Zhao M, Naud MC, Combette JM, Behar-Cohen F. El Zaoui I, et al. J Ocul Pharmacol Ther. 2015 Feb;31(1):17-24. doi: 10.1089/jop.2014.0019. J Ocul Pharmacol Ther. 2015. PMID: 25313830 Free article.

10

A new CRB1 rat mutation links Müller glial cells to retinal telangiectasia.

Zhao M, Andrieu-Soler C, Kowalczuk L, Paz Cortés M, Berdugo M, Dernigoghossian M, Halili F, Jeanny JC, Goldenberg B, Savoldelli M, El Sanharawi M, Naud MC, van Ijcken W, Pescini-Gobert R, Martinet D, Maass A, Wijnholds J, Crisanti P, Rivolta C, Behar-Cohen F. Zhao M, et al. J Neurosci. 2015 Apr 15;35(15):6093-106. doi: 10.1523/JNEUROSCI.3412-14.2015. J Neurosci. 2015. PMID: 25878282 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

336 results

Search Page

Filters